JAK2V617F mutational status and allele burden have little influence on clinical phenotype and prognosis in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis

JAK2V617F突变状态和等位基因负荷对真性红细胞增多症后和原发性血小板增多症后骨髓纤维化患者的临床表型和预后影响甚微。